Search Results

There are 23181 results for: content related to: Bacillus Calmette–Guérin Immunotherapy of Genitourinary Cancer

  1. You have free access to this content
    Bacille Calmette-Guérin in superficial transitional cell carcinoma

    British Journal of Urology

    Volume 82, Issue 2, August 1998, Pages: 213–223, Mungan and Witjes

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1464-410X.1998.00720.x

  2. You have free access to this content
    T-h-2 immunity and CD3+CD45RBlow-activated T cells in mice immunized with recombinant bacillus Calmette–Guérin expressing HIV-1 principal neutralizing determinant epitope

    FEMS Immunology & Medical Microbiology

    Volume 47, Issue 1, June 2006, Pages: 45–55, Vivekanandhan Aravindhan, Sujatha Narayanan, Namasivayam Gautham, Vinayaka Prasad, P. Kannan, William R. Jacobs Jr and Paranji R. Narayanan

    Article first published online : 29 MAR 2006, DOI: 10.1111/j.1574-695X.2006.00061.x

  3. You have free access to this content
    Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity

    Clinical & Experimental Immunology

    Volume 137, Issue 1, July 2004, Pages: 24–34, Y. LUO, H. YAMADA, X. CHEN, A. A. RYAN, D. P. EVANOFF, J. A. TRICCAS and M. A. O'DONNELL

    Article first published online : 10 JUN 2004, DOI: 10.1111/j.1365-2249.2004.02522.x

  4. Bacillus Calmette–Guerin (BCG) for Urothelial Carcinoma of the Bladder

    Emerging Cancer Therapy

    Timothy P. Kresowik, Thomas S. Griffith, Pages: 49–70, 2010

    Published Online : 18 AUG 2010, DOI: 10.1002/9780470626528.ch3

  5. You have free access to this content
    Recombinant bacille Calmette–Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity

    Clinical & Experimental Immunology

    Volume 123, Issue 2, February 2001, Pages: 264–270, Y. Luo, X. Chen, R. Han and M. A. O'Donnell

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.1365-2249.2001.01428.x

  6. You have free access to this content
    Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK

    Molecular Microbiology

    Volume 56, Issue 5, June 2005, Pages: 1302–1313, Danielle Charlet, Serge Mostowy, David Alexander, Louis Sit, Harald G. Wiker and Marcel A. Behr

    Article first published online : 30 MAR 2005, DOI: 10.1111/j.1365-2958.2005.04618.x

  7. You have free access to this content
    Effects of bacillus Calmette-Guérin and interferon-α-2B on human bladder cancer in vitro

    International Journal of Cancer

    Volume 71, Issue 5, 29 May 1997, Pages: 851–857, Ye Zhang, Hoon Eng Khoo and Kesavan Esuvaranathan

    Article first published online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19970529)71:5<851::AID-IJC25>3.0.CO;2-9

  8. Interaction Between Photodynamic Therapy and BCG Immunotherapy Responsible for the Reduced Recurrence of Treated Mouse Tumors

    Photochemistry and Photobiology

    Volume 73, Issue 4, April 2001, Pages: 403–409, Mladen Korbelik, Jinghai Sun and Jeffrey J. Posakony

    Article first published online : 1 MAY 2007, DOI: 10.1562/0031-8655(2001)0730403IBPTAB2.0.CO2

  9. You have free access to this content
    Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette–Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells

    Clinical & Experimental Immunology

    Volume 160, Issue 3, June 2010, Pages: 359–368, Y. Luo, R. Han, D. P. Evanoff and X. Chen

    Article first published online : 10 FEB 2010, DOI: 10.1111/j.1365-2249.2010.04105.x

  10. You have free access to this content
    Long-Term Persistence of BCG Pasteur in Lungs of C57BL/6 Mice Following Intranasal Infection

    Scandinavian Journal of Immunology

    Volume 75, Issue 5, May 2012, Pages: 489–499, N. A. Leversen, L. Sviland, H. G. Wiker and T. Mustafa

    Article first published online : 4 APR 2012, DOI: 10.1111/j.1365-3083.2012.02683.x

  11. You have free access to this content
    Prognostic significance of Bacillus Calmette-Guérin failure classification in non-muscle-invasive bladder cancer

    BJU International

    Volume 110, Issue 6b, September 2012, Pages: E216–E221, Hiroshi Shirakawa, Eiji Kikuchi, Nobuyuki Tanaka, Kazuhiro Matsumoto, Akira Miyajima, So Nakamura and Mototsugu Oya

    Article first published online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10894.x

  12. You have free access to this content
    Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guérin (BCG) in bladder cancer cells

    BJU International

    Volume 112, Issue 6, October 2013, Pages: 781–790, Jung Hoon Kim, Soon-Ja Kim, Kyung Mee Lee and In Ho Chang

    Article first published online : 2 JUL 2013, DOI: 10.1111/bju.12196

  13. You have free access to this content
    Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guérin relapsing non-muscle-invasive bladder cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E508–E513, Kazuhiro Matsumoto, Eiji Kikuchi, Hiroshi Shirakawa, Nozomi Hayakawa, Nobuyuki Tanaka, Akiharu Ninomiya, Akira Miyajima, So Nakamura and Mototsugu Oya

    Article first published online : 10 MAY 2012, DOI: 10.1111/j.1464-410X.2012.11194.x

  14. The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guérin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population

    BJU International

    Luís Lima, Daniela Oliveira, José A. Ferreira, Ana Tavares, Ricardo Cruz, Rui Medeiros and Lúcio Santos

    Article first published online : 13 MAY 2015, DOI: 10.1111/bju.12844

  15. BCG Vaccination in the HIV + Newborn

    AIDS and Tuberculosis: A Deadly Liaison

    Willem A. Hanekom, Gregory D. Hussey, Pages: 55–74, 2009

    Published Online : 21 DEC 2009, DOI: 10.1002/9783527627905.ch3

  16. Intratumoral BCG therapy of transplanted head and neck tumors in strain 2 guinea pigs

    Head & Neck Surgery

    Volume 4, Issue 6, July/August 1982, Pages: 457–467, Priv. Doz. Dr. Jurgen Bier, Dr. Henning Bier, Dr. Steve Kleinschuster and Dr. Herb Rapp

    Article first published online : 18 JUL 2006, DOI: 10.1002/hed.2890040604

  17. Immunotherapy of bladder cancer

    Seminars in Surgical Oncology

    Volume 13, Issue 5, September/October 1997, Pages: 342–349, Unyime O. Nseyo and Donald L. Lamm

    Article first published online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2388(199709/10)13:5<342::AID-SSU8>3.0.CO;2-D

  18. You have free access to this content
    Systemic immune response after intravesical instillation of bacille Calmette–Guérin (BCG) for superficial bladder cancer

    Clinical & Experimental Immunology

    Volume 115, Issue 1, January 1999, Pages: 131–135, TANIGUCHI, KOGA, NISHIKIDO, YAMASHITA, SAKURAGI, KANETAKE and SAITO

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2249.1999.00756.x

  19. SECTION III: Author's investigations

    Acta Ophthalmologica

    Volume 37, Issue S57, November 1959, Pages: 84–181,

    Article first published online : 27 MAY 2009, DOI: 10.1111/j.1755-3768.1959.tb03510.x

  20. BACILLUS CALMETTE-GUERIN (BCG) IMMUNOTHERAPY FOR BLADDER CANCER: REVIEW OF COMPLICATIONS AND THEIR TREATMENT

    Australian and New Zealand Journal of Surgery

    Volume 68, Issue 5, May 1998, Pages: 340–344, David L. Paterson and Anil Patel

    Article first published online : 21 JAN 2008, DOI: 10.1111/j.1445-2197.1998.tb04768.x